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Introduction
potential confounders: education (years of schooling complete), passive smoking (yes, no) , 137 and cumulative exposure to dust in the workplace (years). The association with a history of 138 tuberculosis was estimated for each site using probability weights to allow for the sampling 139 design at each site and then combined in a random effects meta-analysis. The meta-analyses 140 were stratified by gross national income, i.e. high vs low/middle income countries. The level 141 of heterogeneity was summarised using the I 2 statistic. We also regressed FEV1/FVC and 142 FVC (L) as continuous variables against the same independent variables as above. Sensitivity 143 analyses were conducted excluding participants presenting with both airflow obstruction and 144 spirometric restriction. In another set of sensitivity analyses, the association of a history of 145 tuberculosis with airflow obstruction, spirometric restriction, FEV1/FVC, and FVC was 146 assessed omitting all sites with a cooperation rate below 60%. All analyses were conducted 147 using Stata/IC V.12.1 (StataCorp LP, College Station, TX, USA). 
Results

150
The characteristics of the 14,050 participants with acceptable post-bronchodilator spirometry, 151 who responded to the core questionnaire and answered the question on history of tuberculosis 152 are presented, by site, in table 1. There were slightly more females than males, and the overall 153 age ranged from 52.3 to 59.6 across sites. Cumulative smoking exposure, i.e. pack-years, and 154 passive smoking varied widely across sites. The prevalence of a history of tuberculosis [0.7% 155 in Albania (Tirana) to 15.4% in South Africa (Cape Town)] as well as the prevalence of 156 airflow obstruction [6.1% in Estonia (Tartu) and India (Pune) to 19.5% in South Africa (Cape adjusted ORs, and 95% CIs, for this association, by gross national income group and site. 162 Overall, the risk of airflow obstruction in people with a history of tuberculosis was more than 163 twice as much as that of people without such a history (aOR = 2.51, 95% CI 1. 83-3.42 ). This 164 association was stronger in low/middle income sites (aOR = 3.11, 95% CI 2. 30-4.21) and 165 showed no evidence of heterogeneity (I 2 = 0%, P = 0.55). 166 The unadjusted OR, and 95% CI, for the association between spirometric restriction and 167 history of tuberculosis was 2.02 (1.42-2.86). Figure 2 shows adjusted ORs, and 95% CIs, by 168 gross national income group and site for this association. The overall pooled aOR was 2.13 169 (95% CI 1.42-3.19), and significant heterogeneity across sites was recorded (I 2 = 62.4%, P < 170 0.001). In high income sites there was no evidence of heterogeneity (I 2 = 0%; p=0.72) but the 171 risk was low and not significant (aOR = 1.43, 95% CI 0.93, 2.18). In low income countries, 172 although the risk was higher and significant (aOR = 3.19; 95% CI 1.70, 5.99) there was a 173 marked and unexplained heterogeneity in the risk estimates (I 2 = 79.1%; p<0.001).
174
In both figures 1 and 2, ORs are adjusted for age, sex, body mass index, and pack-years.
175
Adjustment for education, passive smoking, and cumulative exposure to dust in the 176 workplace did not materially change the estimates for the effect of tuberculosis. Poland 177 (Krakow) was excluded from the analyses due to insufficient number of participants with for spirometric restriction = 2.11, 95% CI 1.31-3.38), suggesting that these effects are largely 187 independent of each other.
188
The omission of sites with a cooperation rate below 60% did not materially change the results 189 (supplementary figures 3-6). 192 In this population-based study of adults aged 40 years and over, a history of tuberculosis was 193 associated with increased risk of airflow obstruction. A history of tuberculosis was also 194 associated with spirometric restriction, but mainly in sites in low/middle income countries.
191
Discussion
195
The strengths of the present study are: i) its large population-based sample and the inclusion 196 of a great number of sites; ii) the use of a standardised questionnaire for collection of data on 197 risk factors and protocol for spirometry across sites; and iii) the use of post-instead of pre-198 bronchodilator spirometric measurements. The most convincing effect relates to obstruction 199 in low/middle income countries where the odds ratio was high (OR = 3.11) and the results 200 were consistent between sites (I 2 = 0%).
201
Our study also has some limitations. One is its cross-sectional nature, which impedes us from 202 drawing conclusions in terms of temporality and makes us consider the possibility of reverse 203 causation. Tuberculosis is more common in people with some restrictive diseases such as 204 silicosis, but these are relatively very rare. Tuberculosis may also be reactivated in those who 205 take corticosteroids, and particularly inhaled corticosteroid treatment recommended in 206 chronic airway disease. However, their use is rare in this population and even rarer in the 207 low/middle income countries where the association between tuberculosis and airflow 208 obstruction is most pronounced. In some sites response rates were lower than desirable, but 209 when we omitted all sites with a cooperation rate below 60% results did not materially 210 change. Another limitation is the use of data on a self-reported history of tuberculosis, which may suffer from under-reporting due to stigmatisation of the diagnosis. However, differential 212 under-reporting due to stigmatisation between people with and without airflow obstruction or 213 spirometric restriction seems unlikely. It is also possible that several participants have 214 suffered from tuberculosis and healed without any treatment and thus tuberculosis infection 215 may be underestimated. However, in a study in China, the magnitude of the association of 216 airflow obstruction with tuberculosis was similar between self-reports and radiological 217 confirmation (23). According to ATS/ERS (24), pulmonary restriction is defined by a total 218 lung capacity (TLC) less than the fifth percentile of the predicted value. This implies 219 measuring TLC by plethysmography or helium dilution, which is unrealistic in large-scale 220 epidemiological studies, such as this, and especially at centres in low/middle income 221 countries. We are mindful that our choice of FVC as a surrogate of TLC may lead to false 222 positive findings in those with increased residual volumes, but outside the clinical 223 environment the prevalence of this is very low. We are also aware that the use of the 224 NHANES reference equations in our spirometry measurements may overemphasize lung 225 function abnormality in some study sites, but the effect of this is unlikely to be differential as 226 the analyses were done within each site (the sites are ethnically fairly homogeneous) and only 227 then were meta-analysed. In addition, the results from the binary outcomes (FEV1/FVC < 228 LLN, and FVC < LLN) are supported by those of the continuous outcomes (FEV1/FVC, and 229 FVC), which are independent of reference equations.
230
Our findings add to existing knowledge and support the majority of previous smaller studies 231 that have reported an association between airflow obstruction and a history of tuberculosis 232 (10, 11, 25) . We also confirm findings from the few occupational and small hospital-based 233 studies that have observed a decline in lung function associated with both history of and 234 radiographically-confirmed tuberculosis (14-18).
Although it is widely accepted that tuberculosis and the healing process the lung undergoes 236 during and after treatment can cause scarring that leads to loss of parenchymal tissue and 237 restrictive spirometry, it is not clear what mechanisms explain airflow obstruction associated 238 with tuberculosis. The finding that tuberculosis is associated with airflow obstruction, and not 239 only with spirometric restriction, suggests that this is not solely the result of parenchymal 240 scarring. One possibility is that this is caused by bronchiectasis and bronchial stenosis, which 241 can occur as a result of tuberculosis (26). Another possibility is that this is caused by a 242 dysregulation of macrophages arising from latent intracellular infection (27) . Macrophages in 243 the lung act primarily to kill bacteria or to facilitate wound healing and resolution (28), and it 244 is widely accepted that they play a central role in the remodelling that causes chronic airflow 245 obstruction. It is possible that latent mycobacteria in lung macrophages could lead to 246 maintenance of inflammation in the lung and more aggressive remodelling of the airways (28, 247 29).
248
In summary, a history of tuberculosis was associated with both airflow obstruction and 249 spirometric restriction. Nevertheless, large longitudinal studies with post-bronchodilator 250 spirometry are recommended to confirm or refute these findings. With the continuing spread 20.
Miller SD, standard deviation. BMI, body mass index. PB-FEV1, post-bronchodilator forced expiratory volume in 1 second. PB-FVC, post-bronchodilator forced vital capacity. Education, years of schooling complete. *Missing: 3 in Poland (Krakow); 2 in South Africa (Cape Town); and 1 in USA (Lexington). **Missing: 7 in Philippines (Manila); 3 in Philippines (Nampicuan & Talugtug) and Poland (Krakow); 2 in Canada (Vancouver), South Africa (Cape Town) and Netherlands (Maasstricht); and 1 in Iceland (Reykjavik), Morocco (Fes) and Sweden (Uppsala). †Missing: 7 in Philippines (Nampicuan & Talugtug); 5 in England (London); and 1 in Estonia (Tartu), Morocco (Fes), Portugal (Lisbon) and South Africa (Cape Town). ‡Missing: 4 in Netherlands (Maasstricht). 
